IOMED was honored to participate in the recent Multicorporate Matchmaking Event in Health and Medicine Technologies, a high-impact gathering that brings together Europe’s most innovative health tech companies and industry leaders. This event, promoted by the European Commission and organized by Dealflow.eu, aims to create strategic connections between emerging tech companies and major corporations committed to advancing digital health.

Representing IOMED, our CEO, Rohit Mistry, presented our groundbreaking Data Space Platform, which is transforming the way healthcare data is accessed and used in clinical research. IOMED’s platform facilitates high-quality real-world data (RWD) thanks to its federated network of hospitals, converting unstructured data into structured data ready for RWE generation. With our innovations in AI and Natural Language Processing (NLP), the Data Space Platform allows industry and research teams to obtain valuable insights quickly and efficiently.

During the event, IOMED had the opportunity to engage with sector leaders like CUF - Hospitais e Clínicas and Siemens Healthineers, as well as to share our vision and advances with other participating innovators, including Brain+, FrontWave Imaging, GlucoModicum Ltd, Legit.Health, Loop Dx, and Savana, among others.

“This event has been an incredible opportunity to showcase the potential of our Data Space Platform and to strengthen strategic alliances within the sector,” said Rohit Mistry. “We are proud to participate in initiatives that accelerate the development of disruptive health technologies and grateful for the support of the European Commission through the EIC Accelerator.”

The Multicorporate Matchmaking Event allowed IOMED to further its commitment to developing impactful solutions in clinical research and drug development, bringing us one step closer to a future where efficient healthcare data access drives innovation and improves patient care.

‍